Results 51 to 60 of about 3,078,126 (290)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Barriers and facilitators to implementation of intravenous cardiovascular treatments in ambulatory settings

ESC Heart Failure
Aims Intravenous (IV) therapies have transformed the management of various cardiovascular conditions in ambulatory patients. However, uptake of these therapies in ambulatory care settings has several barriers.
Mohamed B. Jalloh, Ian Osoro, James L. Januzzi, Alka Shaunik, M. Cecilia Bahit, Serge Korjian, C. Michael Gibson, Harriette G.C. Van Spall   +7 more
doaj   +1 more source

Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke – Results from the SWISS registry [PDF]

, 2018
Introduction In patients with stroke attributable to cervical artery dissection, we compared endovascular therapy to intravenous thrombolysis regarding three-month outcome, recanalisation and complications.
Simonetti, Barbara Goeggel, Gralla, J., Henrik Gensicke, Steiner, L., Engelter, Stefan T, Philippe A Lyrer, Mueller, H., Susanne Wegener, Weber, J., Kaegi, Georg, Fischer, U., Levke Steiner, Mueller, Hubertus, Muller, Hubertus, Ashraf Eskandari, Nils Peters, Francesco Puccinelli, Sztajzel, R., Kägi, Georg, Lövblad, Karl-Olof, Eskandari, Ashraf, Arnold, M., Luft, A., Stippich, Christoph, Rebekka Kurmann, Kurmann, Rebekka, Bonati, L.H., Simonetti, B.G., Eskandari, A., Andreas Luft, Marcel Arnold, Stippich, C., Patrik Michel, Barbara Goeggel Simonetti, Johannes Weber, Traenka, Christopher, Arnold, Marcel, Christoph Stippich, Engelter, S.T., Steiner, Levke, Sztajzel, Roman, Gralla, Jan, Fischer, Urs, Wegener, S., Lyrer, Philippe A., Puccinelli, F., Urs Fischer, Lovblad, Karl, Jochen Vehoff, Jung, S., Luft, Andreas, Vehoff, J., Bonati, Leo H., Goeggel Simonetti, Barbara, Peters, N., Michel, Patrik, Simon Jung, Lyrer, P.A., Jung, Simon, Weber, Johannes, Bonati, Leo H, Vehoff, Jochen, Gensicke, Henrik, Georg Kägi, Peters, Nils, Lyrer, Philippe A, Karl Lovblad, Stefan T Engelter, Lovblad, K., Christopher Traenka, Traenka, C., Kurmann, R., Kägi, G., Roman Sztajzel, Jan Gralla, Hubertus Mueller, Gensicke, H., Puccinelli, Francesco, Wegener, Susanne, Leo H Bonati, Michel, P.   +80 more
core   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro, Shiwen Koay, Gordon T. Ingle, Patricia McNamara, Laura Watson, Fion Bremner, Valeria Iodice   +6 more
wiley   +1 more source

Administrative risk quantification of subcutaneous and intravenous therapies in Italian centers utilizing the Failure Mode and Effects Analysis approach

ClinicoEconomics and Outcomes Research, 2016
Clemente Ponzetti,1 Monica Canciani,2 Massimo Farina,2 Sara Era,3 Stefan Walzer4,5 1Gruppo Policlinico di Monza, Alessandria, ANMDO National Association of Hospital Physicians, Bologna, 2Studio EmmEffe Srl, Milan, 3Roche Spa, Monza, Italy; 4MArS Market ...
Ponzetti C, Canciani M, Farina M, Era S, Walzer S   +4 more
doaj  

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru, Akansha Chandrasekar, Kyla Blasingame, Jonathan Rosen, Jesse M. Levine, Karla Salazar, Madhuri Chilakapati, Rod Foroozan, Victoria Hardwick, Jonathan M. Yarimi, Nikita Shukla, Timothy E. Lotze, Kristen S. Fisher, Alexander J. Sandweiss   +13 more
wiley   +1 more source

Intravenous solution therapy simplified

Curationis, 1982
The Health Matters Advisory Committee, a statutory body constituted under the Health Act 63 of 1977, appointed a National Intravenous Infusion Rationalisation Committee, consisting of experts from the medical and pharmaceutical professions to investigate
G.W. Schepers
doaj   +1 more source

Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Down syndrome regression disorder is a syndrome characterized by subacute loss of cognitive, behavioral, and functional abilities in individuals with Down syndrome. Electroencephalography abnormalities are frequently observed during evaluation, but it remains unclear whether these findings represent a dynamic marker of disease ...
Jonathan D. Santoro, Mackenzie Silverman, Maeve C. Lucas, Mariam M. Yousuf, Samuel T. Otey, Stella V. Gray, Brittany Jordan, Madeline D. Kahan, Latanya D. Agurs, Michelle Van Hirtum Das, Deborah Holder, Devin King, Eileen A. Quinn, Ryan Kammeyer, Michael S. Rafii   +14 more
wiley   +1 more source

Intravenous therapy [PDF]

Clinical Medicine, 2015
Syed, Haydar, Frances, Asota, Mary, McGinty   +2 more
openaire   +3 more sources

Exercise Reprograms the Spatial Function of Phosphoglycerate Dehydrogenase of a Pathogenic Nuclear Transcription Factor (PHGDH): A Narrative Review

Metabolites
Background: Alzheimer’s disease (AD) represents a significant therapeutic challenge, largely attributed to the complex interplay of genetic and non-genetic mechanisms. Among the latter, metabolic dysregulation has emerged as a critical factor influencing
Dong Yang, Wen Guo, Liang Guo
doaj   +1 more source